Effects of oxygen on kynurenine-3-monooxygenase activity

Author： Dang Y.   Dale W.E.   Brown O.R.  

Publisher： Maney Publishing

ISSN： 1743-2928

Source： Redox Report, Vol.5, Iss.2-3, 2000-04, pp. : 81-84

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntington's Disease

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 6, 2010-12 ,pp. : 791-800

Bentham Science Publishers

Access to resources Recommend Favorite

Flavin-containing monooxygenase 3 and human disease

By Motika Meike S   Zhang Jun   Cashman John R  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 6, 2007-12 ,pp. : 831-845

Informa Healthcare

Access to resources Recommend Favorite

Ketamine may exert antidepressant effects via mediating the kynurenine pathway

By Yang Chun   Zhou Zhiqiang   Shi Jinyun   Yang Jianjun  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 12, 2011-12 ,pp. : 1423-1424

Informa Healthcare

Access to resources Recommend Favorite

Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism

By Cashman John R  

Pharmacogenomics, Vol. 3, Iss. 3, 2002-05 ,pp. : 325-339

Future Medicine

Access to resources Recommend Favorite

The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia

By Richter A.   Hamann M.  

European Journal of Pharmacology, Vol. 478, Iss. 1, 2003-09 ,pp. : 47-52

Elsevier

Access to resources Recommend Favorite